US 11911415
CRISPR/Cas-related methods and compositions for improving transplantation
granted A61KA61K35/28A61P
Quick answer
US patent 11911415 (CRISPR/Cas-related methods and compositions for improving transplantation) held by Editas Medicine, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K35/28, A61P, A61P19/00, A61P3/00